Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ESC 25: The HI-PRO Trial
Author(s): Gregory Piazza Added: 2 months ago
ESC Congress 2025 - HI-PRO shows apixaban 2.5mg twice daily reduced the risk of symptomatic recurrent venous thromboembolism when compared to placebo at 12 months.Dr Gregory Piazza (Brigham and Women's Hospital, US) joins us to discuss findings from the HI-PRO trial, evaluating extended-duration low-intensity apixaban versus placebo for secondary prevention in high-risk patients with provoked… View more

Anticoagulation

Vascular Disease and Surgery
EHRA 25: The European Affera Ventricular Arrhythmia Ablation Registry
Author(s): Frédéric Sacher Added: 7 months ago
EHRA 2025 - Positive safety results of the Affera mapping and ablation system for the treatment of ventricular arrhythmias (VA) show a 6% rate of major complication.Dr Frédéric Sacher (IHU Liryc, Bordeaux, FR) joins us on-site at EHRA Congress 2025 to discuss safety results from the European Affera Ventricular Arrhythmia Ablation Registry, investigating VA ablation with the Affera Sphere-9… View more

Electrophysiology & Arrhythmia
AHA 25: The PFA-SHAM Study
Author(s): Vivek Reddy Added: 3 days ago
AHA 2025 - Dr Vivek Y Reddy (Icahn School of Medicine at Mount Sinai, New York, US) joins us to share findings from the PFA-SHAM study (NCT05717725) investigating pulsed field ablation (PFA) versus sham ablation to treat AF. Patients enrolled in the study underwent an electrophysiology study to ensure they had no concealed AV bypass tract or supraventricular tachycardia, and patients were then… View more

Electrophysiology & Arrhythmia
AHA 25: The DARE-AF Trial
Author(s): Chao Jiang , Zhao Zixu Added: 6 days ago
AHA Scientific Sessions 2025 – Dr Chao Jiang and Dr Zhao Zixu (Beijing Anzhen Hospital, CN) discuss the findings from the DARE-AF (NCT06433479) randomized clinical trial, investigating whether dapagliflozin reduces atrial fibrillation burden following catheter ablation in patients without diabetes or heart failure.This single-center, open-label trial enrolled 200 patients with persistent atrial… View more

Electrophysiology & Arrhythmia
AHA 25: The OCEAN Trial
Author(s): Atul Verma Added: 6 days ago
AHA 2025 - Dr Atul Verma (McGill University Health Centre, Montreal, CA) joins us to share outcomes from OCEAN (NCT02168829). The prospective, open-label, randomised trial aimed to investigate ongoing oral anticoagulation with rivaroxaban 15 mg daily compared to antiplatelet therapy in patients with clinical stroke risk factors at least one year post-successful catheter ablation of AF, left… View more

Anticoagulation

Electrophysiology & Arrhythmia
ESC 25: The SEMA-VR CardioLink-15 Trial
Author(s): Subodh Verma Added: 2 months ago
ESC Congress 2025 - The SEMA-VR CardioLink-15 trial revealed that semaglutide may enhance endogenous progenitor cell-mediated vasculogenic repair processes.Dr Subodh Verma (University of Toronto, Toronto, CA) joins us to discuss the findings from the SEMA-VR CardioLink-15 trial. The study compared usual care with semaglutide, GLP-1RA for six months in 46 patients with either type 2 diabetes… View more

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
Job title: Cardiologist-Electrophysiologist
Dr Francisco Costa is Director of the Electrophysiology Department at Hospital da Luz, SA, Lisbon, Portugal.Dr Costa is an invited speaker and active researcher contributing to multiple international conferences and peer-reviewed journals in cardiac electrophysiology. He is a member of the European Heart Rhythm Association (EHRA) and participates in various scientific committees dedicated to… View more
Gianluigi Savarese headshot
Research Area(s) / Expertise:

Heart Failure

 Job title: Associate Professor of Cardiology
Gianluigi Savarese is an Italian/Swedish cardiologist, currently Associate Professor of Cardiology at Karolinska Institutet (Department of Clinical Science and Education) where he is head of the Center for Heart Failure and Arrhythmia. He is also Senior Consultant for Heart Failure at the Southern Hospital, Stockholm, Sweden. Over the last few years, he has published >400 articles on top peer… View more
Riccardo Inciardi headshot
Research Area(s) / Expertise:

Heart Failure

Echocardiography & Ultrasound

 Job title: Medical Doctor, Cardiologist
Riccardo M. Inciardi is currently Assistant Professor and Consultant in Heart Failure and Echocardiography at the Division of Cardiology at the University Hospital of Brescia (Italy). He is Affiliated to Research at the Center for Heart Failure and Arrhythmia at the Karolinska Institutet (Sweden). Over the last few years, he obtained the PhD Degree in Clinical and Experimental Biomedical Science… View more
Research Area(s) / Expertise: